In addition to these reported complications in TACI CVID patients, healthy C104R mutation carriers seem to be prone to autoimmunity (15), highlighting the complex involvement of TACI in immune homeostasis. The gene discussed is TNFRSF13B; the disease is common variable immunodeficiency.